Spinal Muscular Atrophy Neonatal Screening Program

Plain-language summary

This study evaluates a screening program for the early detection of spinal muscular atrophy (SMA) in newborns. It enrolls babies born in the participating neonatal and pediatric centers, with parental consent. The study does not use a phase designation and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

IRCCS Burlo Garofolo

Intervention

Screening SMA test

Start date

10/16/2023

Estimated completion

5/31/2026

Countries

Italy

Related genes

Locations

• Monfalcone, Italy
• Trieste, Italy

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

INCLUSION CRITERIA

• Live births in the neonatologies and paediatric centers involved in the study.

EXCLUSION CRITERIA

• No consent signed by parents.